| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.11 ▼ -0.80% | Yesterday | $1.12 ▲ +0.33% | Tomorrow's Oncolytics Biotech Inc. Common Stock (ONCY) setup is anchored to $1.12 and targets $1.11 (-0.80%). The near-term read is downside; watch $1.15 / $1.09 because daily realized volatility is about 4.10%. |
Tomorrow's Oncolytics Biotech Inc. Common Stock (ONCY) setup is anchored to $1.12 and targets $1.11 (-0.80%). The near-term read is downside; watch $1.15 / $1.09 because daily realized volatility is about 4.10%. | ||||
| Week | $1.09 ▼ -2.48% | Last Week | $1.13 ▲ +1.04% | The 7-day Oncolytics Biotech Inc. Common Stock model moves from $1.13 to $1.09 (-2.48%). It gives downside momentum context for this stock, so breaks around $1.15 / $1.09 matter more than a single tick. |
The 7-day Oncolytics Biotech Inc. Common Stock model moves from $1.13 to $1.09 (-2.48%). It gives downside momentum context for this stock, so breaks around $1.15 / $1.09 matter more than a single tick. | ||||
| Month | $1.06 ▼ -5.27% | Last Month | $1.14 ▲ +2.21% | The 1-month Oncolytics Biotech Inc. Common Stock target is $1.06 (-5.27%), compared with the live reference near $1.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Oncolytics Biotech Inc. Common Stock target is $1.06 (-5.27%), compared with the live reference near $1.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $1.01 ▼ -9.46% | Last Year | $1.16 ▲ +3.97% | The 1-year Oncolytics Biotech Inc. Common Stock scenario points to $1.01 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Oncolytics Biotech Inc. Common Stock scenario points to $1.01 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $0.9040 ▼ -19.29% | 5 Years Ago | $1.21 ▲ +8.10% | The 5-year Oncolytics Biotech Inc. Common Stock view is $0.9040 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Oncolytics Biotech Inc. Common Stock view is $0.9040 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $1.12 | Mid |
| Daily Change | +0.90% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 59% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $1.12 | Daily Change | +0.90% |
| Market Cap | $120.98M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.